Soluble Prion Peptide 107–120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer’s Disease
Alzheimer’s disease (AD) is the most prevalent form of dementia and soluble amyloid β (Aβ) oligomers are thought to play a critical role in AD pathogenesis. Cellular prion protein (PrP<sup>C</sup>) is a high-affinity receptor for Aβ oligomers and mediates some of their toxic effects. The...
Main Authors: | Elham Rezvani Boroujeni, Seyed Masoud Hosseini, Giulia Fani, Cristina Cecchi, Fabrizio Chiti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7273 |
Similar Items
-
Oligomer technology and applications /
by: 247586 Uglea, Constantin V.
Published: (1998) -
Prion protein protocols /
by: Hill, Andrew F.
Published: (2008) -
Prions and prion diseases : new developments /
by: Verdier, Jean-Michel
Published: (2012) -
Prions and prion diseases : current perspectives /
by: Telling, Glenn C.
Published: (2004) -
Techniques in prion research /
by: Lehmann, Sylvain, et al.
Published: (2004)